When should we measure lipoprotein (a)?
Year: 2013
Type: review
Source: European Heart Journal
Authors: K. M. Kostner, W. Marz, G. M. Kostner
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: lipoprotein(a), cardiovascular risk assessment, cardiovascular disease, atherogenicity, fibrinolysis, secretory phospholipase A2, scavenger receptors, macrophages, farnesoid X receptor, Lp(a)-lowering therapy, PCSK9 inhibitors, cholesterol ester transfer protein inhibitors, microsomal triglyceride transfer protein inhibitor, Lp(a) measurement
Open Access status: closed
OpenAlex ID: W2126617498
